Semaglutide
-
healthHow a 1922 Rescue Mission Explains Ozempic’s $969 US vs. €59 German Price
The identical semaglutide pen costs sixteen times more in the US than in Germany. The price gap traces back to a Canadian discovery, a Danish foundation, and America's unique pharmacy-benefit system.
-
healthFrom Lizard Venom to National Phenomenon: How GLP-1 Drugs Reached One in Eight Americans
A Bronx endocrinologist’s discovery in Gila monster saliva, initially rejected by the government, spawned a class of drugs now used by roughly one in eight U.S. adults for weight loss and diabetes.
-
healthNovo Nordisk Opens Affordable Access to Semaglutide Through Medicare GLP-1 Bridge
Novo Nordisk launches a nationwide Medicare program offering its FDA-approved semaglutide injection and pill for a fixed $50 monthly copay through 2027.
-
healthHealth Canada Greenlights First Generic Semaglutide Injection for Weight Loss
Canada approves Apotex's Svemia, a generic Wegovy alternative, expanding affordable chronic weight management options following a reduced-calorie diet and exercise.
-
healthGLP-1 Medications Linked to Improved Male Fertility and Testosterone Levels
New research presented at ENDO 2026 suggests GLP-1 weight-loss drugs may improve testosterone and sperm quality in obese men, offering a fertility-preserving alternative to traditional hormone replacement therapy.
-
healthGLP-1 Weight Loss Drugs Drive Surge in Cosmetic Body Contouring Procedures
Rapid weight loss from GLP-1 medications like Ozempic is causing sagging skin and volume loss, prompting a significant increase in plastic surgery and body contouring procedures nationwide.
-
healthUK Approves First Daily Oral GLP-1 Semaglutide for Obesity Treatment
Novo Nordisk secures UK approval for daily oral semaglutide, offering a non-injectable alternative for obesity management with significant weight loss results in clinical trials.
-
healthGLP-1 Drugs Show Promise for Joint and Bone Health Beyond Weight Loss
New research highlights how GLP-1 receptor agonists may protect cartilage, bone, and muscle, offering therapeutic potential for osteoarthritis and back pain.